HIV‑1 drug‑resistance mutations and related risk factors among HIV‑1‑positive individuals receiving first-line antiretroviral therapy. Universa Medicina, [S. l.], v. 44, n. 1, p. 57–64, 2025. DOI: 10.18051/UnivMed.2025.v44.57-64. Disponível em: https://univmed.org/ejurnal/index.php/medicina/article/view/1667. Acesso em: 19 apr. 2025.